STOCK TITAN

Retractable Tech (RVP) Financials

RVP
Trailing 12 months to June 30, 2026
Revenue $33.9M -11.2% YoY
Net Income -$3.4M +61.4% YoY
EPS (Diluted) -$0.12 +58.6% YoY
Operating Cash Flow -$5.0M +58.8% YoY
Market Cap $21.4M as of Sep 4, 2026
Price / Sales 0.6x on $33.9M revenue, trailing 12 months to June 30, 2026
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026
Price / Book 0.3x on $72.9M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 4, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the RVP SEC filings page.

Retractable Tech (RVP) reported $33.9M in revenue over the twelve months to Jun 30, 2026, down 11.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI RVP FY2025

Near-zero gross profitability leaves the business dependent on balance-sheet contraction rather than operating leverage or debt financing.

The FY2025 revenue rebound to $38.3M did not rebuild the economics lost since FY2021: gross margin moved from 50.6% to just 0.1%, while operating margin remained deeply negative at -55.3%. With operating cash flow still negative at -$7.1M, the latest loss is not merely an accounting effect; the core business is still not converting sales into cash after production and operating costs.

The balance sheet has contracted alongside the business: assets declined from $206.3M in FY2021 to $142.6M in FY2025, while debt-to-equity stayed exceptionally low at 0.0x. That combination points to a largely unlevered structure whose smaller asset base, rather than rising borrowings, has accompanied the operating deterioration.

Short-term liquidity remains mathematically high, with a current ratio of 6.6x, but reported liquidity equaled only 4.4 months of the latest annual operating outflow. The contrast matters: ample current assets relative to current liabilities coexist with continuing cash use and a fourth consecutive year of operating losses.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 24 / 100
Financial Health Score 24/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Retractable Tech's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
16

Retractable Tech held $2.6M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $7.1M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Retractable Tech scores 16/100 among other emerging companies.

Dilution
74

Retractable Tech had 30M shares outstanding at the end of fiscal year 2025, against 30M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Retractable Tech scores 74/100 among other emerging companies.

R&D Intensity
10

Retractable Tech spent $676K on research and development in fiscal year 2025, which was 1.1% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Retractable Tech scores 10/100 among other emerging companies.

Revenue Progress
35

Retractable Tech reported revenue of $38.3M in fiscal year 2025, against $33.0M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Retractable Tech scores 35/100 among other emerging companies.

Burn Trend
0

Not available for Retractable Tech, and counted as zero in the overall score.

Balance Sheet
7

Retractable Tech's cash, cash equivalents and investments came to $2.6M at the end of fiscal year 2025, against $68.3M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Retractable Tech scores 7/100 among other emerging companies.

Altman Z-Score Distress
0.55

Retractable Tech scores 0.55, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
4/9

Retractable Tech passes 4 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Retractable Tech reported a net loss of $12.6M while operations used $7.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Retractable Tech reported an operating loss of $21.2M against $88K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$7.2M
YoY-31.1%
QoQ+0.3%
5Y CAGR-29.9%
10Y CAGR-0.5%

Retractable Tech generated $7.2M in revenue in Q2 2026. This represents a decrease of 31.1% from the same quarter a year earlier. Against the prior quarter it is up 0.3%.

EBITDA
-$3.2M
YoY+0.3%
QoQ+23.8%

Retractable Tech's EBITDA was -$3.2M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 0.3% from the same quarter a year earlier. Against the prior quarter it is up 23.8%.

Net Income
$2.8M
YoY+3336.2%
QoQ+167.0%
5Y CAGR-23.3%

Retractable Tech reported $2.8M in net income in Q2 2026. This represents an increase of 3336.2% from the same quarter a year earlier. Against the prior quarter it is up 167.0%.

EPS (Diluted)
$0.09
QoQ+164.3%
5Y CAGR-21.9%

Retractable Tech earned $0.09 per diluted share (EPS) in Q2 2026. Against the prior quarter it is up 164.3%.

Cash & Balance Sheet

Free Cash Flow
-$1.8M
YoY+56.7%
QoQ-28.2%

Retractable Tech recorded an outflow of $1.8M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents an increase of 56.7% from the same quarter a year earlier. Against the prior quarter it is down 28.2%.

Cash & Debt
$2.6M
YoY-13.3%
QoQ-4.5%
5Y CAGR-34.8%
10Y CAGR-17.1%

Retractable Tech held $2.6M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding
30M
YoY0.0%
QoQ0.0%
5Y CAGR-2.5%
10Y CAGR+0.1%

Retractable Tech had 30M shares outstanding in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin
2.6%
YoY+3.7pp
QoQ+14.3pp
5Y CAGR-43.6pp
10Y CAGR-31.9pp

Retractable Tech's gross margin was 2.6% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 3.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 14.3 percentage points.

Operating Margin
-71.5%
YoY-22.3pp
QoQ+14.5pp
5Y CAGR-101.3pp

Retractable Tech's operating margin was -71.5% in Q2 2026, reflecting core business profitability. This is down 22.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 14.5 percentage points.

Net Margin
39.3%
YoY+40.2pp
QoQ+98.2pp
5Y CAGR+14.2pp
10Y CAGR+48.0pp

Retractable Tech's net profit margin was 39.3% in Q2 2026, showing the share of revenue converted to profit. This is up 40.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 98.2 percentage points.

Return on Equity
3.9%
YoY+4.0pp
QoQ+9.9pp
5Y CAGR-10.4pp
10Y CAGR+6.1pp

Retractable Tech's ROE was 3.9% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 4.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 9.9 percentage points.

Capital Allocation

R&D Spending
$187K
YoY+17.0%
QoQ+9.9%
5Y CAGR-14.0%

Retractable Tech invested $187K in research and development in Q2 2026. This represents an increase of 17.0% from the same quarter a year earlier. Against the prior quarter it is up 9.9%.

Capital Expenditures
$30K
YoY-91.0%
QoQ+378.9%

Retractable Tech invested $30K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 91.0% from the same quarter a year earlier. Against the prior quarter it is up 378.9%.

Share Buybacks

Not reported for Q2 2026.

RVP Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RVP quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$7.2M-31.1%$7.2M-13.5%$9.4M+4.0%$10.1M-2.5%$10.4M+73.2%$8.3M+9.2%$9.1M-36.5%$10.3M+0.1%
Cost of Revenue$7.0M-33.6%$8.0M-3.4%$11.0M-5.2%$8.4M-18.9%$10.6M+63.6%$8.3M+45.6%$11.6M-9.3%$10.4M+72.3%
Gross Profit$191K+278.2%-$838K-43772.7%-$1.5M+38.7%$1.7M+11483.6%-$107K+74.5%-$2K-100.1%-$2.5M-261.9%-$15K-100.3%
R&D Expenses$187K+17.0%$170K-10.9%$125K-20.9%$199K+14.2%$160K-19.6%$191K+34.4%$158K-2.4%$175K+15.7%
SG&A Expenses$3.6M+12.9%$3.4M+18.8%$3.1M-7.3%$3.6M+11.2%$3.2M-12.7%$2.9M-12.9%$3.4M+24.4%$3.2M-14.5%
Operating Income-$5.1M-0.3%-$6.2M-31.9%-$7.7M-6.8%-$3.7M+28.9%-$5.1M+11.0%-$4.7M-56.6%-$7.2M-159.8%-$5.1M-448.8%
EBITDA-$3.2M+0.3%-$4.3M-52.6%-$5.6M-4.4%-$1.8M+44.6%-$3.3M+15.9%-$2.8M-154.8%-$5.3M-394.8%-$3.2M-421.2%
Interest Expense$19K-16.0%$20K-12.9%$22K-19.1%$21K-32.5%$22K-30.0%$23K-29.9%$27K-23.8%$30K-15.5%
Income Tax$2K+1.3%$2K-99.4%$2K+1.8%$2K+105.4%$2K-100.0%$286K+233.9%$2K-93.2%-$31K+97.5%
Net Income$2.8M+3336.2%-$4.2M+59.8%-$2.3M-162.3%$371K+119.3%-$87K+99.4%-$10.5M-2545.5%$3.8M+5269.3%-$1.9M+52.7%
EPS (Basic)$0.09-$0.14+60.0%-$0.08-161.5%$0.01+114.3%$0.00+100.0%-$0.35-3600.0%$0.13-$0.07+50.0%
EPS (Diluted)$0.09-$0.14+60.0%-$0.08-161.5%$0.01+114.3%$0.00+100.0%-$0.35-3600.0%$0.13-$0.07+50.0%
Diluted Shares (Avg)30M0.0%30M0.0%N/A30M0.0%30M0.0%30M0.0%N/A30M0.0%

RVP Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RVP quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$141.7M-3.7%$137.6M-7.8%$142.6M-11.3%$146.4M-7.2%$147.1M-8.5%$149.3M-15.2%$160.7M-10.5%$157.8M-13.1%
Current Assets$65.9M+4.6%$60.0M-5.8%$63.1M-13.9%$64.1M-6.7%$63.0M-10.7%$63.7M-15.9%$73.3M-5.6%$68.8M-11.6%
Cash & Equivalents$2.6M-13.3%$2.8M-18.2%$2.6M-38.9%$3.4M-12.1%$3.0M-55.6%$3.4M-66.2%$4.2M-66.6%$3.9M-65.2%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$15.9M-22.1%$16.4M-22.4%$17.2M-10.4%$20.4M-4.3%$20.4M-7.1%$21.2M+8.7%$19.2M+9.1%$21.3M-5.2%
Accounts Receivable$9.0M+11.7%$7.0M+30.2%$7.9M+1.5%$8.4M-2.7%$8.1M+72.4%$5.4M-27.8%$7.8M-27.0%$8.7M+6.0%
Long-Term Investments$0$0$0$0$0$0$0$0
Total Liabilities$68.8M-2.5%$67.5M-7.1%$68.3M-7.2%$69.7M-6.3%$70.6M-6.2%$72.7M-4.7%$73.6M-8.5%$74.4M-9.4%
Current Liabilities$13.4M+48.7%$10.4M+10.0%$9.6M+9.3%$9.6M+20.1%$9.0M+21.1%$9.5M+38.2%$8.8M-6.4%$8.0M-13.4%
Non-Current Liabilities$55.5M-10.0%$57.1M-9.7%$58.7M-9.4%$60.0M-9.5%$61.6M-9.2%$63.2M-9.0%$64.8M-8.8%$66.3M-8.9%
Long-Term DebtN/AN/A$896K-0.5%$624K-36.8%$718K-33.0%$807K-30.0%$900K-27.0%$987K-24.8%
Total Equity$72.9M-4.7%$70.1M-8.5%$74.4M-14.7%$76.8M-8.0%$76.5M-10.5%$76.6M-23.1%$87.2M-12.2%$83.5M-16.1%
Retained Earnings$12.4M-22.6%$9.6M-40.5%$13.9M-48.0%$16.3M-29.1%$16.0M-36.0%$16.1M-58.9%$26.7M-31.2%$23.0M-41.0%

Not reported in any period shown, so not listed: Goodwill.

RVP Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RVP quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow-$1.7M+53.6%-$1.4M+7.3%-$597K+46.0%-$1.3M+78.0%-$3.7M-38.2%-$1.5M+27.1%-$1.1M-158.3%-$5.7M-173.4%
Depreciation & Amortization$1.9M+1.3%$1.9M+1.2%$2.1M+13.7%$1.9M-2.1%$1.9M-0.8%$1.9M-0.3%$1.9M+10.9%$1.9M-1.8%
Capital Expenditures$30K-91.0%$6K-92.8%N/A$90K-88.7%$332K+173.0%$87K-61.6%$298K+93.9%$794K+455.5%
Free Cash Flow-$1.8M+56.7%-$1.4M+12.0%N/A-$1.3M+79.3%-$4.1M-44.0%-$1.6M+30.5%-$1.4M-180.6%-$6.5M-185.1%
Investing Cash Flow$1.8M-49.0%$1.7M+122.0%-$115K-107.4%$1.8M-38.5%$3.5M+1197.4%$762K+251.6%$1.6M+548.6%$2.9M+624.7%
Financing Cash Flow-$198K-40.8%-$147K-5.2%-$145K-5.6%-$142K-6.1%-$141K-5.9%-$140K-6.3%-$137K-0.5%-$134K-4.3%

Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.

RVP Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RVP quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Gross Margin2.6%+3.7pp-11.7%-11.7pp-16.2%+11.3pp16.7%+16.9pp-1.0%+5.9pp0.0%-25.0pp-27.5%-38.3pp-0.1%-42.0pp
Operating Margin-71.5%-22.3pp-85.9%-29.6pp-81.7%-2.1pp-36.2%+13.4pp-49.1%+46.5pp-56.4%-17.1pp-79.6%-60.1pp-49.6%-40.6pp
Net Margin39.3%+40.2pp-58.9%-24.9%-66.4pp3.7%+22.3pp-0.8%-126.6%41.6%+42.1pp-18.6%+20.7pp
Return on Equity3.9%+4.0pp-6.0%+7.7pp-3.2%-7.5pp0.5%+2.8pp-0.1%+16.5pp-13.7%-14.1pp4.3%+4.4pp-2.3%+1.8pp
Return on Assets2.0%+2.1pp-3.1%+4.0pp-1.7%-4.0pp0.3%+1.5pp-0.1%+8.8pp-7.0%-7.3pp2.4%+2.4pp-1.2%+1.0pp
Current Ratio4.93-2.1x5.74-1.0x6.57-1.8x6.66-1.9x7.01-2.5x6.70-4.3x8.34+0.1x8.57+0.2x
Debt-to-Equity0.94+0.9x0.96+1.0x0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x
Asset Turnover0.050.0x0.050.0x0.070.0x0.070.0x0.070.0x0.060.0x0.060.0x0.070.0x
FCF Margin-24.5%+14.5pp-19.1%-0.3ppN/A-13.4%+49.6pp-38.9%+7.9pp-18.8%+10.8pp-15.5%-27.6pp-63.0%-137.1pp

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Retractable Tech RVP FY2025 $38.3M -$12.6M -32.8% $21.4M 24/100
Nexgel Inc NXGL FY2025 $11.4M -$3.0M -26.3% $3.1M 37/100
Harvard Biosci HBIO FY2025 $86.5M -$56.7M -65.5% $36.5M 38/100
Precision Optics POCI FY2025 $19.1M -$5.8M -30.3% $47.6M 26/100
Bionano Genomics Inc BNGO FY2025 $28.5M -$26.4M -92.6% $14.1M 56/100
Meihua International Medical Technologies Co., Ltd. MHUA FY2025 $61.8M $6.8M 11.0% $425.4M 59/100

Frequently Asked Questions

What is Retractable Tech's annual revenue?

Retractable Tech (RVP) reported $38.3M in total revenue for fiscal year 2025. This represents a 15.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Retractable Tech's revenue growing?

Retractable Tech (RVP) revenue grew by 15.8% year-over-year, from $33.0M to $38.3M in fiscal year 2025.

Is Retractable Tech profitable?

No, Retractable Tech (RVP) reported a net income of -$12.6M in fiscal year 2025, with a net profit margin of -32.8%.

Retractable Tech (RVP) reported diluted earnings per share of -$0.43 for fiscal year 2025. This represents a -7.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Retractable Tech (RVP) had EBITDA of -$13.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Retractable Tech (RVP) had $2.6M in cash and equivalents against $896K in long-term debt.

Retractable Tech (RVP) had a gross margin of 0.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Retractable Tech (RVP) had an operating margin of -55.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Retractable Tech (RVP) had a net profit margin of -32.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Retractable Tech (RVP) has a return on equity of -16.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Retractable Tech (RVP) recorded an outflow of $7.1M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Retractable Tech (RVP) had $142.6M in total assets as of fiscal year 2025, including both current and long-term assets.

Retractable Tech (RVP) invested $676K in research and development during fiscal year 2025.

Retractable Tech (RVP) had 30M shares outstanding as of fiscal year 2025.

Retractable Tech (RVP) had a current ratio of 6.57 as of fiscal year 2025, which is generally considered healthy.

Retractable Tech (RVP) had a debt-to-equity ratio of 0.01 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Retractable Tech (RVP) had a return on assets of -8.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Retractable Tech (RVP) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $21.4M as of Sep 4, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Retractable Tech (RVP) trades at 0.6x sales, its market capitalization divided by revenue of $33.9M revenue, trailing 12 months to June 30, 2026. The market capitalization is $21.4M as of Sep 4, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, Retractable Tech (RVP) held $2.6M in cash, cash equivalents and investments, and reported an operating cash outflow of $7.1M over that year. Dividing the one by the other, the reported balance equals about 4 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Retractable Tech (RVP) has an Altman Z-Score of 0.55, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Retractable Tech (RVP) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Retractable Tech (RVP) reported a net loss of $12.6M while operations used $7.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Retractable Tech (RVP) reported an operating loss of $21.2M against $88K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Retractable Tech (RVP) scores 24 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top